Institutional investors hold a majority ownership of ZTS through the 94.25% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended December 2017, these large investors purchased a net $8.1 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
POLEN CAPITAL MANAGEMENT LLC Bought 4.0 Million shares of Zoetis Inc
BESSEMER INVESTMENT MANAGEMENT L... Bought 2.1 Million shares of Zoetis Inc
MILLENNIUM MANAGEMENT LLC Bought 1.3 Million shares of Zoetis Inc